Navigation Links
Tengion to Host Conference Call to Provide a Business Update and Report First Quarter 2011 Financial Results on May 12, 2011
Date:5/4/2011

lantation in patients at risk for kidney failure. Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment™ for the treatment of neurogenic bladder. Tengion has worldwide rights to its product candidates. For more information, please visit www.tengion.com.


'/>"/>
SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Tengion Announces Addition of Two Renal Experts to Research & Development Advisors Panel
2. Tengion To Host Conference Call To Provide a Business Update and Report Fourth Quarter 2010 Financial Results on March 25, 2011
3. Tengion Announces Pricing of $31.4 Million Private Placement
4. Tengion Addresses Recent Trading Activity in its Common Stock
5. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
6. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
7. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
8. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
9. Tengion Appoints A. Brian Davis Chief Financial Officer
10. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
11. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... WriteResult, a premier provider of ePRO technologies ... School of Public Health and New Haven Farms to ... month-long project. The goal of the study was to ... free access to fresh produce and nutrition education on ... high blood pressure, diabetes and weight gain. Patients completed ...
(Date:3/25/2015)... 25, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... result of recent discussions with certain shareholders representing approximately ... Company, after dealing with certain matters including the appointment ... shareholders on March 26, 2015 (the "Meeting") it intends ... directors will take place when the Meeting reconvenes. The ...
(Date:3/25/2015)... YORK , March 25, 2015  S&P ... commenced Factual Stock Report coverage on Abattis ... (OTCQX: ATTBF; CSE: ATT): is a specialty biotechnology ... of cultivating, licensing and marketing proprietary ingredients, bio-similar ... markets in North America . ...
(Date:3/25/2015)... SHANGHAI , CAMBRIDGE, Mass. and ... -- WuXi NextCODE, which provides comprehensive capabilities for using the ... deCODE genetics on their publication of the largest studies of ... published today online in Nature Genetics ... date of sequence variation, authored by a team of deCODE ...
Breaking Biology Technology:Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 2Yale and New Haven Farms Improving Patient Health with WriteResult's myPROpad™ 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2
... 15, 2010 Ocera Therapeutics, Inc. announced today ... safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which ...  OCR-002 recently received Orphan Drug status and Fast ... Drug Administration for the treatment of hyperammonemia (excessive ...
... brain-machine interface designed to help paralyzed subjects move objects with ... arm providing sensory feedback, a new study from the University ... into the movement of a computer cursor or an external ... these early systems, vision was the only tool a subject ...
... 2010 The Association for Career and Technical Education ... Role in Worker Retraining" that describes how career and ... adults and providing them the skills needed to re-enter the ... not only focus on local employment needs, but are also ...
Cached Biology Technology:Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy 2Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy 3Robot arm improves performance of brain-controlled device 2Robot arm improves performance of brain-controlled device 3ACTE Releases Issue Brief Outlining Critical Role CTE Plays in Worker Retraining 2
(Date:3/10/2015)... 10, 2015  Continuing its 167-year history of offering ... introduces The Eye Scanning Password Authenticator , a ... to secure websites or sensitive data. Employing ... international borders, the device has a small camera that ... the iris, converting them into an encrypted ID that ...
(Date:3/5/2015)... March 5, 2015 In Brazil ... companies already using these solutions and 42 percent planning to ... latter, approximately 25 percent of the companies will be investing ... the majority of companies in the region are currently opting ... hybrid model will command significant attention in the coming years. ...
(Date:3/2/2015)... HUNTSVILLE, Ala. , March 2, 2015 /PRNewswire/ ... transaction processing. Data protection company Tharon Rankins Enterprises ... product that provides an ultra-safe way for businesses ... as their financial transactions. Beconux ... by Tharon Rankins Enterprises. Functioning similarly to an ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Personal Data Protection Company Launches New Product 2
... mutations caused by a father,s lifestyle can be inherited by ... more, these findings show that mutations in the germ-line are ... germ cells. This means that a father,s lifestyle has the ... just his immediate offspring. These findings were published in the ...
... India , July 1, 2013 /PRNewswire-iReach/ -- Description ... the human body in all of its intricacies is the ... ANATOMY AND PHYSIOLOGY is one such tool that provides enormous ... and their physiology. (Photo: http://photos.prnewswire.com/prnh/20130701/CG41015 ) ...
... -- Like most other things, you can have too much ... and new research proves it. According to an article published ... of Leukocyte Biology , wound healing can be delayed ... promote healing. An overabundance of these cells, however, also causes ...
Cached Biology News:Gene mutations caused by a father's lifestyle can be inherited by multiple generations 2Animated Essential Atlas of Anatomoy and Physiology Anatomy Atlas 2Too much of a good thing? Too many 'healing' cells delays wound healing 2
Mouse BLC/BCA 1 - 10kDa...
Human SPARC-like 1 Biotinylated Affinity Purified PAb...
, Glycerol 30%...
Please email us with project details and we will respond within 24 hours to your query!...
Biology Products: